About
Improved specialty pharmaceuticals and treatments for new areas of use
Areas of Focus
Categories
DiagnosticsSmall Molecule PharmaceuticalDrug Delivery & FormulationNJ, NY, PA
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
5
As Collaborator
2
Total Enrollment
2,230
By Phase
NA: 2PHASE3: 2PHASE4: 2PHASE2: 1
By Status
COMPLETED: 6TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04948307Lead Sponsor
OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
NACompleted
437 participants
Started: Jun 30, 2021 · Completed: May 10, 2023
NCT02243670Collaborator
Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy
NACompleted
9 participants
Started: Aug 31, 2016 · Completed: Mar 31, 2017
NCT01908842Lead Sponsor
Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults
PHASE3Completed
759 participants
Started: Aug 31, 2013 · Completed: Apr 30, 2014
NCT01903005Lead Sponsor
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
PHASE4Completed
668 participants
Started: Jul 31, 2013 · Completed: Sep 30, 2014
NCT01848054Lead Sponsor
Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
PHASE3Completed
313 participants
Started: Jun 30, 2013 · Completed: Jan 31, 2014
Locations (1)
Headquarters
Morristown, NJ, United States
Map
Loading map...